Hong Kong · Delayed Price · Currency is HKD CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 11.88 billion. The enterprise value is 10.83 billion.
| Market Cap | 11.88B |
| Enterprise Value | 10.83B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding.
| Current Share Class | 132.67M |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.07% |
| Owned by Institutions (%) | 10.76% |
| Float | 159.89M |
Valuation Ratios
The trailing PE ratio is 253.26 and the forward PE ratio is 25.43.
| PE Ratio | 253.26 |
| Forward PE | 25.43 |
| PS Ratio | 8.33 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 230.76 |
| EV / Sales | 7.59 |
| EV / EBITDA | 81.68 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.39 |
| Quick Ratio | 3.82 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 8.10 |
| Debt / FCF | -4.79 |
| Interest Coverage | -2.55 |
Financial Efficiency
Return on equity (ROE) is 0.82% and return on invested capital (ROIC) is -1.56%.
| Return on Equity (ROE) | 0.82% |
| Return on Assets (ROA) | -0.60% |
| Return on Invested Capital (ROIC) | -1.56% |
| Return on Capital Employed (ROCE) | -1.15% |
| Weighted Average Cost of Capital (WACC) | 10.37% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | 41,371 |
| Employee Count | 1,134 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.89 |
Taxes
In the past 12 months, HKG:6185 has paid 7.44 million in taxes.
| Income Tax | 7.44M |
| Effective Tax Rate | 13.68% |
Stock Price Statistics
The stock price has decreased by -51.69% in the last 52 weeks. The beta is 1.24, so HKG:6185's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -51.69% |
| 50-Day Moving Average | 25.84 |
| 200-Day Moving Average | 30.89 |
| Relative Strength Index (RSI) | 44.51 |
| Average Volume (20 Days) | 10,902,113 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 1.43 billion and earned 46.91 million in profits.
| Revenue | 1.43B |
| Gross Profit | 1.05B |
| Operating Income | -80.79M |
| Pretax Income | 54.35M |
| Net Income | 46.91M |
| EBITDA | 126.17M |
| EBIT | -80.79M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 2.13 billion in cash and 1.07 billion in debt, with a net cash position of 1.06 billion or 4.27 per share.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 1.07B |
| Net Cash | 1.06B |
| Net Cash Per Share | 4.27 |
| Equity (Book Value) | 5.75B |
| Book Value Per Share | n/a |
| Working Capital | 2.88B |
Cash Flow
In the last 12 months, operating cash flow was -31.12 million and capital expenditures -192.81 million, giving a free cash flow of -223.92 million.
| Operating Cash Flow | -31.12M |
| Capital Expenditures | -192.81M |
| Depreciation & Amortization | 209.61M |
| Net Borrowing | -1.07B |
| Free Cash Flow | -223.92M |
| FCF Per Share | -0.91 |
Margins
Gross margin is 73.76%, with operating and profit margins of -5.66% and 3.29%.
| Gross Margin | 73.76% |
| Operating Margin | -5.66% |
| Pretax Margin | 3.81% |
| Profit Margin | 3.29% |
| EBITDA Margin | 8.85% |
| EBIT Margin | -5.66% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 79.20% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.39% |
| FCF Yield | -1.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:6185 is 47.54, which is 84.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 47.54 |
| Price Target Difference | 84.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 30.92% |
| EPS Growth Forecast (3Y) | 167.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |